MIBG/I-131 (solution for injection)

MI-23

Indications

  • Diagnostic scintigraphic localisation of tumours originating in tissue that embryologically stems from the neural crest. These are pheochromocytomas, paragangliomas, chemodectomas and ganglioneuromas.
  • Detection, staging and follow-up on therapy of neuroblastomas.
  • Evaluation of the uptake of iobenguane. The sensitivity to diagnostic visualisation is different for the listed pathologic entities. Pheochromocytomas and neuroblastomas are sensitive in approx. 90% of patients, carcinoids in 70% and MCT in only 35%.
  • Functional studies of the adrenal medulla (hyperplasia) and the myocardium (sympathetic innervation).

Labelling activity
?

Shelf life
30 h after the hour and date of manufacturing (expiry date is given on the packaging)

Shelf-life and storage conditions after radiolabelling

  • at temperature below 25ºC (protect from light)

Radioisotope Centre POLATOM works for over 60 years as a major Polish supplier of radiopharmaceuticals, sealed and standard radiation sources, radionuclide generators, radiochemical reagents, and custom radioactive preparations for medicine, research, industry and environmental monitoring.

POLATOM operates under the umbrella of National Centre for Nuclear Research (NCBJ) and delivers products — including diagnostic kits using 99mTc, iodine-131 therapies, sealed gamma sources, and calibration standards — to thousands of customers across dozens of countries worldwide.